jolkinolide b has been researched along with cytochrome c-t in 1 studies
Studies (jolkinolide b) | Trials (jolkinolide b) | Recent Studies (post-2010) (jolkinolide b) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
---|---|---|---|---|---|
35 | 0 | 27 | 11,809 | 21 | 5,125 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, H; Jiang, L; Lin, Y; Liu, J; Xu, H; Yue, L | 1 |
1 other study(ies) available for jolkinolide b and cytochrome c-t
Article | Year |
---|---|
Jolkinolide B induces apoptosis in MDA-MB-231 cells through inhibition of the PI3K/Akt signaling pathway.
Topics: Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Chromones; Cytochromes c; Diterpenes; Drugs, Chinese Herbal; Female; Humans; Membrane Potential, Mitochondrial; Mitochondria; Morpholines; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2012 |